Warren Bickel, whose addiction research and products helped put Roanoke, Virginia’s Fralin Biomedical Research Institute at ...

Less than a third of FDA-mandated trials for drugs approved between 2015 and 2021 had been completed by May 2024.

Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...

WellSpan Health has been approved for a nearly $1 million funding award by the Patient-Centered Outcomes Research Institute ...

Avi Kapoor Rare Genetic Diseases Of Obesity-Focused Rhythm Pharma's Bardet-Biedl Syndrome Drug Meets Primary Goal In Pediatric Trial During the R&D event for investors, Rhythm Pharmaceuticals Inc ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

In this randomized controlled trial of pediatric patients with congenital adrenal hyperplasia (CAH), it was found that ...

Cerebral adrenoleukodystrophy (CALD) is a rare progressive, genetic brain disease that primarily presents in young boys, causing loss of neurological function and ultimately leading to early death.

The FDA will decide on new drugs for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.

Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...

The annual Payment Notice prescribes standards and rules that govern insurers and health insurance Marketplaces under the ACA ...